The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
S.J.A. Society, Inc., Thomas P. Johnson, and Thomas Alan Blair
Sunshine Act Meetings - In the Matter of Automotive Breakthrough Sciences, Inc.
Cadence Design Systems, Inc.
Cadence agreed to settle charges that its acquisition of Cooper & Chyan Technology, Inc. would reduce competition for "routing" software used to automate the design of integrated circuits or microchips. According to the complaint, the merger would reduce Cadence's incentives to permit competing suppliers of routing tools to obtain access to its layout environments resulting in less innovation, higher prices, and reduced services. To ensure that independent software developers of commercial routing tools continue to compete with Cooper & Chyan's technology, the consent order requires Cadence to allow the developers to participate in Cadence's software interface programs.
Notice Regarding Compliance Assistance and Civil Penalty Leniency Policies for Small Entities
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Mediq Inc.orporated
Mediq abandoned its proposed acquisition of Universal Hospital Services after the Commission filed a complaint and motion for a preliminary injunction to block the merger of the nation's two largest firms engaged in the rental to hospitals of movable medical equipment, such as respiratory, infusion and monitoring devices. The complaint, filed in the U.S. District Court for the District of Columbia, alleged that the merger would create a monopoly for movable medical equipment rental in many major metropolitan areas across the nation.
Sunshine Act Meeting - In the Matter of Automotive Breakthrough Sciences, Inc.
Apple Computer, Inc., In the Matter of
Deceptive Use of "Leakproof," "Guaranteed Leakproof," Etc., As Descriptive of Dry Cell Batteries - 16 CFR Part 403
Opinion 97-7
CVS Corporation, and Revco D.S., Inc.
CVS agreed to settle allegations that its acquisition of Revco would substantially reduce competition for the retail sale of pharmacy services to health insurance companies and other third-party payers in Virginia and in the Binghamton, New York metropolitan area. The consent order requires the divestiture of 114 Revco stores in Virginia and 6 pharmacy counters in Binghamton.
In March, 1998, CVS Corporation agreed to pay a $600,000 civil penalty to settle Federal Trade Commission charges that the company violated a 1997 consent order and asset maintenance agreement it signed with the agency to settle charges stemming from CVS's 1997 acquisition of Revco D.S., Inc.